News
Lynne Meadow, the artistic director of the influential Manhattan Theatre Club for 53 years, has announced that she will step ...
What an enlightening and fun Founders Day it was! It was special for all of us who were able to get to two Dietrich Theater ...
Lilly presents first clinical data for its investigational, next-generation FRα targeting ADC in platinum-resistant ovarian cancer at the 2025 ASCO Annual Meeting PR Newswire Jun 2, 2025, 5:00:00 AM ...
Learn about the executive team and board of directors at Eli Lilly and Co (LLY:XNYS) and review their bios and compensation over the latest fiscal years.
According to Lilly, STX-478 could potentially address 30%-40% of people with HR-positive breast cancer, with a profile that could allow it to be used more readily in combination with other therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results